Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BPH and sexuality.

A R Zlotta1, C C Schulman

  • 1Department of Urology, Erasme Hospital, University Clinics of Brussels, Belgium.

European Urology
|July 7, 1999
PubMed
Summary
This summary is machine-generated.

Patient quality of life is key in benign prostatic hyperplasia (BPH) management. This review examines how BPH treatments impact sexual function, an often-overlooked aspect important to patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.

Bladder cancer (Amsterdam, Netherlands)·2016
Same author

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

British journal of cancer·2014
Same author

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

British journal of cancer·2012
Same author

Erectile dysfunction and cardiovascular diseases.

Archivos espanoles de urologia·2010
Same author

Role of surgery in high-risk localized prostate cancer.

Current oncology (Toronto, Ont.)·2010

Area of Science:

  • Urology
  • Men's Health
  • Sexual Medicine

Background:

  • Quality of life (QoL) is increasingly vital in benign prostatic hyperplasia (BPH) care.
  • Patient-reported outcomes, particularly concerning sexual function post-therapy, are critical considerations.

Purpose of the Study:

  • To review the impact of current benign prostatic hyperplasia therapies on sexual function.
  • To highlight the importance of sexual health in the context of BPH management.

Main Methods:

  • Literature review of current medical, surgical, and instrumental treatments for symptomatic BPH.
  • Analysis of studies investigating the effects of these therapies on sexual function.

Main Results:

  • Sexual function is frequently affected by BPH treatments, a factor often neglected in past research.

Related Experiment Videos

  • Various therapeutic modalities for BPH carry different implications for sexual health.

    • Conclusions:

    • Understanding the impact on sexual function is essential for comprehensive BPH management.
    • Future research and clinical practice should prioritize sexual health outcomes in BPH patients.